Research Spotlight · Hepatology & Internal Medicine Fatty…

Research Spotlight · Hepatology & Internal Medicine Fatty liver disease is one of the most common conditions we encounter and historically one of the most therapeutically frustrating. That may be about to change. Scientists have found that combining two existing, already-approved drugs can dramatically reduce liver fat in models of fatty liver disease. Crucially, the combination also showed potential to lower broader metabolic risk, not just the liver numbers.